Roche: back in black.

Fonction Financial News

Swiss pharma group, Roche, has recorded a strong financial performance in 2003, swinging from a loss of CHF4 billion in 2002 to a net profit of CHF3 billion ($2.48 billion).

The company's growth had "significantly" outpaced the global market, with total sales up by six per cent to CHF31.2 billion.

Roche also expects to grow faster than its peers this year.

The group is the world's leading maker of cancer medicines and is also receiving a boost for sales of drugs to treat hepatitis, anaemia...

Pour continuer la lecture


VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT